DanielSOryMD
Cardiology • Saint Louis, MOProfessor, Internal Medicine, Washington University School of Medicine
Are you Dr. Ory?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 53 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
4570 Childrens Pl
Saint Louis, MO 63110Phone+1 314-362-7601Fax+1 314-362-0186
Summary
- Dr. Daniel Ory, MD is a cardiologist in Saint Louis, Missouri. He is currently licensed to practice medicine in Missouri and Massachusetts. He is a Professor at Washington University School of Medicine.
Education & Training
Massachusetts General HospitalFellowship, Cardiovascular Disease, 1989 - 1992
Brigham and Women's HospitalResidency, Internal Medicine, 1986 - 1989
Harvard Medical SchoolClass of 1986
Certifications & Licensure
MA State Medical License 1988 - 2025
MO State Medical License 1995 - 2020- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2005
Clinical Trials
- Study of IV VTS-270 for Infantile Liver Disease Associated With Niemann-Pick Disease, Type C Start of enrollment: 2019 Feb 22
Publications & Presentations
PubMed
- 68 citationsThe Niemann-Pick Disease Genes: Regulators of Cellular Cholesterol HomeostasisDaniel S. Ory
Trends in Cardiovascular Medicine. 2004-02-01 - 348 citationsChronic Cyclodextrin Treatment of Murine Niemann-Pick C Disease Ameliorates Neuronal Cholesterol and Glycosphingolipid Storage and Disease ProgressionCristin Davidson, Nafeeza Ali, Matthew C. Micsenyi, Gloria Stephney, Sophie Renault
Plos One. 2009-09-11 - 353 citationsLysosomal cholesterol activates mTORC1 via an SLC38A9-Niemann-Pick C1 signaling complexBrian M. Castellano, Ashley M. Thelen, Ofer Moldavski, McKenna Feltes, Reini E. N. van der Welle
Science. 2017-03-24
Press Mentions
Casma Therapeutics Receives Grant from Michael J. Fox Foundation to Support Parkinson’s Drug DevelopmentMay 29th, 2019
Casma Therapeutics Expands Executive Team with Appointment of Two Senior Vice PresidentsAugust 6th, 2018
Sucampo to Host 2017 R&D Day on November 16 in New YorkOctober 11th, 2017
Grant Support
- Mechanism Of Oxysterol Activation Of Membrane CholesterolNational Heart, Lung, And Blood Institute2011–2012
- Regulation Of Cholesterol Homeostasis By Noncoding RNASNational Heart, Lung, And Blood Institute2010–2012
- Lipid Biomarkers For Diabetic ComplicationsNational Heart, Lung, And Blood Institute2009–2010
- Oxysterols, Atherosclerosis And Metabolic SyndromeNational Heart, Lung, And Blood Institute2006–2010
- Mechanism Of Endocytic Trafficking Of CholesterolNational Heart, Lung, And Blood Institute2002–2009
- The Niemann-Pick Disease Genes Regulators Of Cellular Cholesterol HomeostasisNational Center For Research Resources2006
- Nuclear Receptor Signaling In The Control Of Cholesterol HomeostasisNational Center For Research Resources2006
- Molecular Mechanism Of Cellular Cholesterol TraffickingNational Heart, Lung, And Blood Institute2001–2005
- Gene Transfer In A Model Of AtheroschlerosisNational Heart, Lung, And Blood Institute1995–1996
- Gene Transfer In A Model Of AtheroschlerosisNational Heart, Lung, And Blood Institute1994
- Gene Transfer In A Rabbit Model Of AtheroschlerosisNational Heart, Lung, And Blood Institute1992–1993
